Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with non-hormonal agents: Combined analysis of four phase-2 trials

BACKGROUND: Multiple phase-2 trials in men with biochemically-recurrent prostate cancer (BRPC) have assessed the impact of non-hormonal agents on PSA kinetics. We have previously demonstrated that changes in PSA kinetics correlate with metastasis-free survival; however, it is unknown whether these c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate Cancer Prostatic Dis
Main Authors: Suzman, Daniel L., Zhou, Xian C., Zahurak, Marianna L., Lin, Jianqing, Antonarakis, Emmanuel S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4323734/
https://ncbi.nlm.nih.gov/pubmed/25384338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2014.44
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados